279 related articles for article (PubMed ID: 29380693)
1. Hepatitis C Virus Mediated Metastasis in Hepatocellular Carcinoma as a Therapeutic Target for Cancer Management.
Khera L; Paul C; Kaul R
Curr Drug Metab; 2018; 19(3):224-235. PubMed ID: 29380693
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1.
Khera L; Paul C; Kaul R
Virology; 2017 Jun; 506():110-120. PubMed ID: 28376369
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein interacts with cellular metastasis suppressor Nm23-H1 and promotes cell migration and invasion.
Paul C; Khera L; Kaul R
Arch Virol; 2019 May; 164(5):1271-1285. PubMed ID: 30859475
[TBL] [Abstract][Full Text] [Related]
4. Complex interactions between microRNAs and hepatitis B/C viruses.
Fan HX; Tang H
World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation.
Ninio L; Nissani A; Meirson T; Domovitz T; Genna A; Twafra S; Srikanth KD; Dabour R; Avraham E; Davidovich A; Gil-Henn H; Gal-Tanamy M
Cells; 2019 Nov; 8(11):. PubMed ID: 31694343
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-associated cancer.
Lin MV; King LY; Chung RT
Annu Rev Pathol; 2015; 10():345-70. PubMed ID: 25387053
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC.
Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196
[TBL] [Abstract][Full Text] [Related]
8. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma.
Vescovo T; Refolo G; Vitagliano G; Fimia GM; Piacentini M
Clin Microbiol Infect; 2016 Oct; 22(10):853-861. PubMed ID: 27476823
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis C virus infection and hepatocarcinogenesis].
Szalay F
Orv Hetil; 2010 Sep; 151(38):1524-9. PubMed ID: 20826376
[TBL] [Abstract][Full Text] [Related]
11. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
Perez S; Kaspi A; Domovitz T; Davidovich A; Lavi-Itzkovitz A; Meirson T; Alison Holmes J; Dai CY; Huang CF; Chung RT; Nimer A; El-Osta A; Yaari G; Stemmer SM; Yu ML; Haviv I; Gal-Tanamy M
PLoS Genet; 2019 Jun; 15(6):e1008181. PubMed ID: 31216276
[TBL] [Abstract][Full Text] [Related]
13. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
14. Role of Oxidative Stress in Hepatitis C Virus Induced Hepatocellular Carcinoma.
Fu N; Yao H; Nan Y; Qiao L
Curr Cancer Drug Targets; 2017; 17(6):498-504. PubMed ID: 27677955
[TBL] [Abstract][Full Text] [Related]
15. Role of antiviral therapy in the management of hepatocellular carcinoma.
Guan YS; He Q
Anticancer Drugs; 2013 Apr; 24(4):337-43. PubMed ID: 23388161
[TBL] [Abstract][Full Text] [Related]
16. Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
Motoyama H; Tamori A; Kubo S; Uchida-Kobayashi S; Takemura S; Tanaka S; Ohfuji S; Teranishi Y; Kozuka R; Kawamura E; Hagihara A; Morikawa H; Enomoto M; Murakami Y; Kawada N
PLoS One; 2018; 13(3):e0194163. PubMed ID: 29534101
[TBL] [Abstract][Full Text] [Related]
17. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
Ringelhan M; Heikenwalder M; Protzer U
Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals.
Hazari S; Hefler HJ; Chandra PK; Poat B; Gunduz F; Ooms T; Wu T; Balart LA; Dash S
World J Gastroenterol; 2011 Jan; 17(3):300-12. PubMed ID: 21253388
[TBL] [Abstract][Full Text] [Related]
19. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic activity of hepatitis B and C viruses.
Vrancken K; Paeshuyse J; Liekens S
Antivir Chem Chemother; 2012 Jan; 22(4):159-70. PubMed ID: 22182803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
